• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 GEO 数据库的帕金森病差异 microRNA 的筛选及其临床验证。

Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification.

机构信息

Department of Neurology, Ganzhou People's Hospital, Ganzhou 341000, Jiangxi Province, China.

Department of Pharmacy, Ganzhou Fifth People's Hospital, Ganzhou 341000, Jiangxi Province, China.

出版信息

Biomed Res Int. 2021 Nov 13;2021:8171236. doi: 10.1155/2021/8171236. eCollection 2021.

DOI:10.1155/2021/8171236
PMID:34812409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8605920/
Abstract

OBJECTIVE

This study is set out to explore the potential difference of miR in PD through GEO data and provide diagnostic indicators for clinical practice.

METHODS

In this study, differential miR was screened through the Gene Expression Omnibus (GEO) database, 68 PD patients treated in our hospital from May 2017 to March 2018 were collected as the research group (RG), and 50 normal subjects who underwent physical examination in our hospital during the same period were collected as the control group (CG). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression and diagnostic value of miR-374a-5p in serum of patients. The potential target genes of miR-374a-5p were predicted, and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Gene Ontology Consortium (GO) were carried out.

RESULTS

GEO2R analysis revealed that 193 miRs are expressed differentially, of which 78 were highly expressed and 115 were poorly expressed. The miR-374a-5p expression in the serum of the RG was reduced markedly and had a diagnostic value. Targetscan and miRDB online websites were used to predict their target genes, with 415 common target genes. miR-374a-5p may participate in 27 functional pathways and 8 signal pathways.

CONCLUSION

miR-335-5p has low expression in PD and is expected to be a potential diagnostic indicator.

摘要

目的

本研究通过 GEO 数据探讨 PD 中 miR 的潜在差异,为临床实践提供诊断指标。

方法

本研究通过基因表达综合数据库(GEO)筛选差异表达的 miR,收集 2017 年 5 月至 2018 年 3 月我院治疗的 68 例 PD 患者作为研究组(RG),同期我院体检的 50 例正常受试者作为对照组(CG)。采用实时定量聚合酶链反应(qRT-PCR)检测患者血清中 miR-374a-5p 的表达及诊断价值。预测 miR-374a-5p 的潜在靶基因,并进行京都基因与基因组百科全书(KEGG)分析和基因本体联合会(GO)分析。

结果

GEO2R 分析显示,有 193 个 miRs 表达差异,其中 78 个高表达,115 个低表达。RG 血清中 miR-374a-5p 表达明显降低,具有诊断价值。靶标扫描和 miRDB 在线网站预测其靶基因,有 415 个共同靶基因。miR-374a-5p 可能参与 27 个功能途径和 8 个信号途径。

结论

miR-335-5p 在 PD 中低表达,有望成为潜在的诊断指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/44e9da22dfa7/BMRI2021-8171236.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/0bb9854dcdfb/BMRI2021-8171236.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/b23f0fe86b74/BMRI2021-8171236.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/a63351275b86/BMRI2021-8171236.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/44e9da22dfa7/BMRI2021-8171236.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/0bb9854dcdfb/BMRI2021-8171236.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/b23f0fe86b74/BMRI2021-8171236.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/a63351275b86/BMRI2021-8171236.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8cd/8605920/44e9da22dfa7/BMRI2021-8171236.004.jpg

相似文献

1
Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification.基于 GEO 数据库的帕金森病差异 microRNA 的筛选及其临床验证。
Biomed Res Int. 2021 Nov 13;2021:8171236. doi: 10.1155/2021/8171236. eCollection 2021.
2
Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.miR-182-5p 在肺鳞癌中的临床价值:一项结合 TCGA、GEO 数据和 RT-qPCR 验证的研究。
World J Surg Oncol. 2018 Apr 10;16(1):76. doi: 10.1186/s12957-018-1378-6.
3
Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.通过microRNA和mRNA表达谱的综合分析揭示microRNA在非酒精性脂肪性肝病免疫发病机制中的作用
Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):65-79. doi: 10.1016/s1499-3872(16)60098-x.
4
Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.基于基因表达综合数据库(GEO)的卵巢癌中 MicroRNA-9 的前瞻性通路信号和预后价值:一项生物信息学分析。
J Ovarian Res. 2021 Feb 9;14(1):29. doi: 10.1186/s13048-021-00779-z.
5
Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.几种来源于血清细胞外囊泡的 miRNA 可能是帕金森病早期诊断和进展的潜在生物标志物。
Transl Neurodegener. 2021 Jul 28;10(1):25. doi: 10.1186/s40035-021-00249-y.
6
Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.miR-145-5p在非小细胞肺癌中的临床价值及潜在分子机制探索:一项基于GEO、qRT-PCR和TCGA数据的回顾性研究
Tumour Biol. 2017 Mar;39(3):1010428317691683. doi: 10.1177/1010428317691683.
7
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
8
Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.循环 microRNAs 作为颅内动脉瘤破裂的潜在分子生物标志物。
Mol Diagn Ther. 2020 Jun;24(3):351-364. doi: 10.1007/s40291-020-00465-8.
9
Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.miR-452-5p在前列腺癌肿瘤发生中的作用:一项基于癌症基因组图谱(TCGA)、基因表达综合数据库(GEO)及生物信息学分析的研究
Pathol Res Pract. 2018 May;214(5):732-749. doi: 10.1016/j.prp.2018.03.002. Epub 2018 Mar 6.
10
Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.采用微阵列和 RT-qPCR 评估 miR-198-5p 在肺鳞癌中的临床价值。
World J Surg Oncol. 2018 Feb 2;16(1):22. doi: 10.1186/s12957-018-1320-y.

引用本文的文献

1
Cohort-specific boolean models highlight different regulatory modules during Parkinson's disease progression.特定队列的布尔模型在帕金森病进展过程中突出了不同的调控模块。
iScience. 2024 Sep 14;27(10):110956. doi: 10.1016/j.isci.2024.110956. eCollection 2024 Oct 18.
2
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases.miRNAs 在神经退行性疾病中的作用机制及治疗前景。
Behav Neurol. 2023 Nov 23;2023:8537296. doi: 10.1155/2023/8537296. eCollection 2023.
3
Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration.

本文引用的文献

1
LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy.LINC00473/miR-374a-5p 通过靶向 SPIN1 调节食管鳞癌,削弱放疗的作用。
J Cell Biochem. 2019 Sep;120(9):14562-14572. doi: 10.1002/jcb.28717. Epub 2019 Apr 24.
2
miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.miR-374a-5p 通过靶向三阴性乳腺癌中的 ARRB1 促进肿瘤进展。
Cancer Lett. 2019 Jul 10;454:224-233. doi: 10.1016/j.canlet.2019.04.006. Epub 2019 Apr 17.
3
Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
脑警报:自身细胞外核酸引发的神经炎症到神经退行性变。
J Biomed Sci. 2023 Aug 7;30(1):64. doi: 10.1186/s12929-023-00954-y.
4
State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis.作为帕金森病和阿尔茨海默病生物标志物及治疗靶点的微小RNA特征研究现状:一项系统综述与荟萃分析
Biomedicines. 2023 Apr 7;11(4):1113. doi: 10.3390/biomedicines11041113.
5
The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement.非编码RNA在帕金森病发病机制中的作用:最新进展
Pharmaceuticals (Basel). 2022 Jun 30;15(7):811. doi: 10.3390/ph15070811.
在帕金森病小鼠中,受抑制的微小RNA-96通过靶向CACNG5使丝裂原活化蛋白激酶(MAPK)信号通路失活,从而抑制诱导型一氧化氮合酶(iNOS)表达和多巴胺能神经元凋亡。
Mol Med. 2018 Nov 28;24(1):61. doi: 10.1186/s10020-018-0059-9.
4
The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress.帕金森病基因产物 DJ-1 调节 miR-221 以促进神经元在氧化应激下的存活。
Redox Biol. 2018 Oct;19:62-73. doi: 10.1016/j.redox.2018.07.021. Epub 2018 Aug 3.
5
Hippocampal microRNA-mRNA regulatory network is affected by physical exercise.海马体 microRNA-mRNA 调控网络受体育锻炼影响。
Biochim Biophys Acta Gen Subj. 2018 Aug;1862(8):1711-1720. doi: 10.1016/j.bbagen.2018.05.004. Epub 2018 May 8.
6
Parkinson's disease psychosis: presentation, diagnosis and management.帕金森病性精神病:表现、诊断与管理
Neurodegener Dis Manag. 2017 Dec;7(6):365-376. doi: 10.2217/nmt-2017-0028. Epub 2017 Nov 21.
7
Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer.表达频率较低的微小RNA影响结直肠癌诊断后的生存率。
Oncotarget. 2017 Aug 3;8(48):83845-83859. doi: 10.18632/oncotarget.19863. eCollection 2017 Oct 13.
8
MicroRNA in cardiovascular biology and disease.心血管生物学与疾病中的微小RNA
Adv Clin Exp Med. 2017 Aug;26(5):865-874. doi: 10.17219/acem/62915.
9
Biomarkers for Parkinson's Disease: Recent Advancement.帕金森病的生物标志物:最新进展。
Neurosci Bull. 2017 Oct;33(5):585-597. doi: 10.1007/s12264-017-0183-5. Epub 2017 Sep 21.
10
Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.帕金森病患者血清 microRNA 29 家族表达下调。
Sci Rep. 2017 Jul 14;7(1):5411. doi: 10.1038/s41598-017-03887-3.